Home › NDC Lookup › RxCUI directory › RxCUI 2668095

0.4 ML adalimumab-afzb 50 MG/ML Prefilled Syringe — RxCUI 2668095

RxNorm drug concept · Semantic clinical drug
RxCUI 2668095 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2668095
Official name0.4 ML adalimumab-afzb 50 MG/ML Prefilled Syringe
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asadalimumab-afzb 20 MG per 0.4 ML Prefilled Syringe; adalimumab-afzb 20 MG in 0.4 ML Prefilled Syringe; adalimumab-afzb 50 MG/ML per 0.4 ML Prefilled Syringe
FDA products mapped3
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Adalimumab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Adalimumab is approved for quite a few inflammatory conditions — rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psor...
  • What conditions is adalimumab actually approved to treat?
  • You'll use either an autoinjector pen or a prefilled syringe, depending on what your doctor prescribes. Before injecting, take it out of the refrigerator and let it sit for 15 to 3...
  • How do I give myself this injection at home?
📖 Read our full Adalimumab Injection guide →

🕸️ Concept Web — How 0.4 ML adalimumab-afzb 50 MG/ML Prefilled Syring... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 0.4 ML adalimumab-afzb 50 MG/ML Prefilled Syringe RxCUI 2668095

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Adalimumab 327361
    • Adalimumab-afzb 2619155
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Abrilada 2668066
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Adalimumab Prefilled Syringe 727702
    • Adalimumab-afzb Prefilled Syringe 2668073
    • Adalimumab Injectable Product 1163691
    • Adalimumab-afzb Injectable Product 2668062
    • Adalimumab Prefilled Syringe [Abrilada] 2668076
    • Adalimumab-afzb Prefilled Syringe [Abrilada] 2668077
    • Abrilada Injectable Product 2668068
    • Prefilled Syringe 721656
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Adalimumab-afzb 50 MG/ML SCDC · 2668061
  • Adalimumab Prefilled Syringe SCDF · 727702
  • Adalimumab-afzb Prefilled Syringe SCDFP · 2668073
  • Adalimumab Injectable Product SCDG · 1163691
  • Adalimumab-afzb Injectable Product SCDGP · 2668062

Brand-Name Concepts

  • 0.4 ML adalimumab-afzb 50 MG/ML Prefilled Syringe [Abrilada] SBD · 2668096
  • Adalimumab-afzb 50 MG/ML [Abrilada] SBDC · 2668067
  • Adalimumab Prefilled Syringe [Abrilada] SBDF · 2668076
  • Adalimumab-afzb Prefilled Syringe [Abrilada] SBDFP · 2668077
  • Abrilada Injectable Product SBDG · 2668068
  • Abrilada BN · 2668066

📦 FDA Products & Package NDCs

3 products · 4 package NDCs
4 package NDCs map to RxCUI 2668095 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00025-0325-01 1 KIT in 1 CARTON (0025-0325-01) / 1 KIT in 1 KIT * .8 mL... ABRILADA Pfizer Laboratories Div Pfizer Inc 2023-12-14
00025-0325-02 2 KIT in 1 CARTON (0025-0325-02) / 1 KIT in 1 KIT * .8 mL... ABRILADA Pfizer Laboratories Div Pfizer Inc 2023-12-14
00025-0328-02 2 KIT in 1 CARTON (0025-0328-02) / 1 KIT in 1 KIT * 1 SYRI... ABRILADA Pfizer Laboratories Div Pfizer Inc 2023-12-14
00025-0333-02 2 KIT in 1 CARTON (0025-0333-02) / 1 KIT in 1 KIT * 1 SYRI... ABRILADA Pfizer Laboratories Div Pfizer Inc 2023-12-14
Observed labelers: Pfizer Laboratories Div Pfizer Inc (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.